申请人:Bristol-Myers Squibb Company
公开号:US20130085147A1
公开(公告)日:2013-04-04
The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS5A protein.
本公开涉及抗病毒化合物,更具体地涉及能够抑制丙型肝炎病毒(HCV)编码的NS5A蛋白质功能的化合物,包含这些化合物的组合物,以及抑制NS5A蛋白质功能的方法。